Figure 2.

Distribution of CDI patients in the two clinical trials (003 and 004), by ATLAS score. The number of mITT patients in each of the groups who have available values for all analyzed variables: study 003 (n=515), study 004 (n=452), combined studies (n=967).

Miller et al. BMC Infectious Diseases 2013 13:148   doi:10.1186/1471-2334-13-148
Download authors' original image